PICK A TIME SLOT
₹ Price not available
Book an appointment for Consultation
₹ Price not available
You will receive an SMS with a verification code on this number.
Are you new to hospital ?
We have sent you an OTP on
Resend OTP
Did not receive OTP? You can request for another OTP. Click on Resend OTP
Go Back
Your appointment is
confirmed.
The details will be shared via Email & SMS
Note :Temporary visitor restriction, only one attendant is permitted with the patient. Your cooperation is solicited.
Dr. Mandal completed his MBBS from N.R.S Medical College, Kolkata in the year of 2008. Following this he completed his M.D. in General Medicine from Calcutta National Medical College, Kolkata in 2015, his D.M. in Medical Oncology from Tata Memorial Hospital, Mumbai 2019. Further, he holds an MRCP in the field of Medical Oncology (Specialty Certificate Examination) and accomplished it in the year 2019, and in the same year, he derived his ESMO certification, thus known as a certified practising consultant medical oncologist henceforth. Dr Mandal specialises in the treatment of oncological and haematological disorders such as managing solid tumours like gastrointestinal, genitourinary, lung, head and neck, gynaecological, breast cancers and haematological malignancies like acute leukaemias, multiple myeloma and lymphomas. He has also been part of many clinical trials.
- ESMO (European society of medical oncologists)
- ISMPO (Indian society of medical and paediatric oncologists)
- ASCO (American society of clinical oncologists)
- IOSI (Immune-oncological Society of India)
- Bengali
- English
- Hindi
- World Eligibility for Treatment-Free Remission in Chronic Myeloid Leukaemia Patients from a Tertiary Cancer Centre in India – presented at the international CML conference-2017 (iCMLf).
- Long-term and short-term outcomes in patients of chronic myeloid leukaemia treated with generic and innovator imatinib- a retrospective analysis- presented at international CML conference-2017 (iCMLf).
- Outcomes of Chronic Myeloid Leukemia-Chronic Phase Patients Treated with Generic Imatinib- Report from Tata Memorial Hospital- oral presentation in Annual meeting for Mumbai Hematology Group - March 2018.
- Trastuzumab Emtansine in HER2 positive metastatic breast cancer: A real-world experience - e poster in ASCO- 2018, ASCO Abstract #226633.
- RMAC study: A randomised study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation, Oral Oncology, Volume 128,2022,105816, ISSN 1368-8375, https://doi.org/10.1016/j.oraloncology.2022.105816.
- Osteosarcoma journey over two decades in India: Small steps, big changes- Pediatric Blood Cancer. 2019;66:e27877. https://doi.org/10.1002/pbc.27877.
- Influence of hypothyroidism post chemoradiation on outcomes in head and neck cancer- DOI: 10.1200/JCO.2018.36.15_suppl.e18066 Journal of Clinical Oncology 36, no. 15_suppl. Published online June 01, 2018.
- Demography and pattern of care of patients with head-and-neck carcinoma: Experience from a tertiary care centre in North India- DOI: 10.4103/crst.crst_286_20.
- Outcomes of Patients with Splenic Marginal Zone Lymphoma Treated with Rituximab or Splenectomy: Report from Tertiary Cancer Center in India- DOI: https://doi.org/10.1016/j.clml.2018.07.216.
- Patil VM, Noronha V, Joshi A, Mandal TK, Bhattacharjee A, Goel A, et al. Hypothyroidism post-chemoradiation on outcomes in head-and-neck cancer. Cancer Res Stat Treat 2018; 1:84-91. https://www.crstonline.com/text.asp?2018/1/2/84/258535.
- Choudhary, A.K., Abraham, G., Patil, V.M. et al. Audit of Demographics, Treatment Patterns and Outcomes of Differentiated Thyroid Cancers Treated with Tyrosine Kinase Inhibitors. Indian J Surg Oncol (2021). https://doi.org/10.1007/s13193-021-01445-y.
- Mandal TK, Roy S, Singh S, Lali BS, Chowdhury Z, Nayak L. Blastic plasmacytoid dendritic cell neoplasm of the thigh: A case report and narrative review of the literature. Cancer Res Stat Treat [serial online] 2020 [cited 2021 Dec 8]; 3:630-4. Available from: https://www.crstonline.com/text.asp?2020/3/3/630/295540.
- Srinivas S, Roy S, Mandal TK, Das S. A Varanasi experience. Cancer Res Stat Treat [serial online] 2020 [cited 2021 Dec 8];3:160-1. Available from: https://www.crstonline.com/text.asp?2020/3/1/160/279083.
- Kanteti, A.P.K., Abraham, G., Patil, V.M. et al. An Audit of Systemic Therapy in Medullary Carcinoma Thyroid. Indian J Surg Oncol (2021). https://doi.org/10.1007/s13193-021-01381-x.
- Roy S, Mandal TK, Nayak L, Gupta A, Shetty DL. Primary osseous Burkitt lymphoma mimicking multiple myeloma – A case report and literature review. J Appl Hematol [serial online] 2021 [cited 2021 Dec 8];12:37-40. Available from: https://www.jahjournal.org/text.asp?2021/12/1/37/311324.
- Venetoclax – The Game-changer in Hematology- CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2020; 41(04): 555-558. DOI: 10.4103/ijmpo.ijmpo_260_20.
- Cutaneous Involvement of Systemic Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma- CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2020; 41(02): 239-240. DOI: 10.4103/ijmpo.ijmpo_72_20.
- Splenic marginal zone lymphoma relapsing as miliary lung mottling: an unusual presentation- DOI: https://doi.org/10.5045/br.2018.53.2.103.
- Subarachnoid haemorrhage caused by Moya Moya disease with no intracranial aneurysm-A rare case report. Indian Medical Journal, Volume-108, 15 December 2014 Annexure. pISSN No.-0091-5871.
- A case of Disseminated NCC infection as Immune Reconstitution Inflammatory Syndrome in an HIV patient""- Indian Medical Journal, Volume-108, 15 September 2014 Annexure. pISSN No.-0091-5871.
Overview
Fellowship & Membership
Languages Spoken
Awards & Achievements
Talks & Publications
- ESMO (European society of medical oncologists)
- ISMPO (Indian society of medical and paediatric oncologists)
- ASCO (American society of clinical oncologists)
- IOSI (Immune-oncological Society of India)
Dr. Mandal completed his MBBS from N.R.S Medical College, Kolkata in the year of 2008. Following this he completed his M.D. in General Medicine from Calcutta National Medical College, Kolkata in 2015, his D.M. in Medical Oncology from Tata Memorial Hospital, Mumbai 2019. Further, he holds an MRCP in the field of Medical Oncology (Specialty Certificate Examination) and accomplished it in the year 2019, and in the same year, he derived his ESMO certification, thus known as a certified practising consultant medical oncologist henceforth. Dr Mandal specialises in the treatment of oncological and haematological disorders such as managing solid tumours like gastrointestinal, genitourinary, lung, head and neck, gynaecological, breast cancers and haematological malignancies like acute leukaemias, multiple myeloma and lymphomas. He has also been part of many clinical trials.
- Bengali
- English
- Hindi
- World Eligibility for Treatment-Free Remission in Chronic Myeloid Leukaemia Patients from a Tertiary Cancer Centre in India – presented at the international CML conference-2017 (iCMLf).
- Long-term and short-term outcomes in patients of chronic myeloid leukaemia treated with generic and innovator imatinib- a retrospective analysis- presented at international CML conference-2017 (iCMLf).
- Outcomes of Chronic Myeloid Leukemia-Chronic Phase Patients Treated with Generic Imatinib- Report from Tata Memorial Hospital- oral presentation in Annual meeting for Mumbai Hematology Group - March 2018.
- Trastuzumab Emtansine in HER2 positive metastatic breast cancer: A real-world experience - e poster in ASCO- 2018, ASCO Abstract #226633.
- RMAC study: A randomised study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation, Oral Oncology, Volume 128,2022,105816, ISSN 1368-8375, https://doi.org/10.1016/j.oraloncology.2022.105816.
- Osteosarcoma journey over two decades in India: Small steps, big changes- Pediatric Blood Cancer. 2019;66:e27877. https://doi.org/10.1002/pbc.27877.
- Influence of hypothyroidism post chemoradiation on outcomes in head and neck cancer- DOI: 10.1200/JCO.2018.36.15_suppl.e18066 Journal of Clinical Oncology 36, no. 15_suppl. Published online June 01, 2018.
- Demography and pattern of care of patients with head-and-neck carcinoma: Experience from a tertiary care centre in North India- DOI: 10.4103/crst.crst_286_20.
- Outcomes of Patients with Splenic Marginal Zone Lymphoma Treated with Rituximab or Splenectomy: Report from Tertiary Cancer Center in India- DOI: https://doi.org/10.1016/j.clml.2018.07.216.
- Patil VM, Noronha V, Joshi A, Mandal TK, Bhattacharjee A, Goel A, et al. Hypothyroidism post-chemoradiation on outcomes in head-and-neck cancer. Cancer Res Stat Treat 2018; 1:84-91. https://www.crstonline.com/text.asp?2018/1/2/84/258535.
- Choudhary, A.K., Abraham, G., Patil, V.M. et al. Audit of Demographics, Treatment Patterns and Outcomes of Differentiated Thyroid Cancers Treated with Tyrosine Kinase Inhibitors. Indian J Surg Oncol (2021). https://doi.org/10.1007/s13193-021-01445-y.
- Mandal TK, Roy S, Singh S, Lali BS, Chowdhury Z, Nayak L. Blastic plasmacytoid dendritic cell neoplasm of the thigh: A case report and narrative review of the literature. Cancer Res Stat Treat [serial online] 2020 [cited 2021 Dec 8]; 3:630-4. Available from: https://www.crstonline.com/text.asp?2020/3/3/630/295540.
- Srinivas S, Roy S, Mandal TK, Das S. A Varanasi experience. Cancer Res Stat Treat [serial online] 2020 [cited 2021 Dec 8];3:160-1. Available from: https://www.crstonline.com/text.asp?2020/3/1/160/279083.
- Kanteti, A.P.K., Abraham, G., Patil, V.M. et al. An Audit of Systemic Therapy in Medullary Carcinoma Thyroid. Indian J Surg Oncol (2021). https://doi.org/10.1007/s13193-021-01381-x.
- Roy S, Mandal TK, Nayak L, Gupta A, Shetty DL. Primary osseous Burkitt lymphoma mimicking multiple myeloma – A case report and literature review. J Appl Hematol [serial online] 2021 [cited 2021 Dec 8];12:37-40. Available from: https://www.jahjournal.org/text.asp?2021/12/1/37/311324.
- Venetoclax – The Game-changer in Hematology- CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2020; 41(04): 555-558. DOI: 10.4103/ijmpo.ijmpo_260_20.
- Cutaneous Involvement of Systemic Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma- CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2020; 41(02): 239-240. DOI: 10.4103/ijmpo.ijmpo_72_20.
- Splenic marginal zone lymphoma relapsing as miliary lung mottling: an unusual presentation- DOI: https://doi.org/10.5045/br.2018.53.2.103.
- Subarachnoid haemorrhage caused by Moya Moya disease with no intracranial aneurysm-A rare case report. Indian Medical Journal, Volume-108, 15 December 2014 Annexure. pISSN No.-0091-5871.
- A case of Disseminated NCC infection as Immune Reconstitution Inflammatory Syndrome in an HIV patient""- Indian Medical Journal, Volume-108, 15 September 2014 Annexure. pISSN No.-0091-5871.
Fellowship & Membership
Overview
Languages Spoken
Awards & Achievements
Talks & Publications
- Bengali
- English
- Hindi
Dr. Mandal completed his MBBS from N.R.S Medical College, Kolkata in the year of 2008. Following this he completed his M.D. in General Medicine from Calcutta National Medical College, Kolkata in 2015, his D.M. in Medical Oncology from Tata Memorial Hospital, Mumbai 2019. Further, he holds an MRCP in the field of Medical Oncology (Specialty Certificate Examination) and accomplished it in the year 2019, and in the same year, he derived his ESMO certification, thus known as a certified practising consultant medical oncologist henceforth. Dr Mandal specialises in the treatment of oncological and haematological disorders such as managing solid tumours like gastrointestinal, genitourinary, lung, head and neck, gynaecological, breast cancers and haematological malignancies like acute leukaemias, multiple myeloma and lymphomas. He has also been part of many clinical trials.
- ESMO (European society of medical oncologists)
- ISMPO (Indian society of medical and paediatric oncologists)
- ASCO (American society of clinical oncologists)
- IOSI (Immune-oncological Society of India)
- World Eligibility for Treatment-Free Remission in Chronic Myeloid Leukaemia Patients from a Tertiary Cancer Centre in India – presented at the international CML conference-2017 (iCMLf).
- Long-term and short-term outcomes in patients of chronic myeloid leukaemia treated with generic and innovator imatinib- a retrospective analysis- presented at international CML conference-2017 (iCMLf).
- Outcomes of Chronic Myeloid Leukemia-Chronic Phase Patients Treated with Generic Imatinib- Report from Tata Memorial Hospital- oral presentation in Annual meeting for Mumbai Hematology Group - March 2018.
- Trastuzumab Emtansine in HER2 positive metastatic breast cancer: A real-world experience - e poster in ASCO- 2018, ASCO Abstract #226633.
- RMAC study: A randomised study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation, Oral Oncology, Volume 128,2022,105816, ISSN 1368-8375, https://doi.org/10.1016/j.oraloncology.2022.105816.
- Osteosarcoma journey over two decades in India: Small steps, big changes- Pediatric Blood Cancer. 2019;66:e27877. https://doi.org/10.1002/pbc.27877.
- Influence of hypothyroidism post chemoradiation on outcomes in head and neck cancer- DOI: 10.1200/JCO.2018.36.15_suppl.e18066 Journal of Clinical Oncology 36, no. 15_suppl. Published online June 01, 2018.
- Demography and pattern of care of patients with head-and-neck carcinoma: Experience from a tertiary care centre in North India- DOI: 10.4103/crst.crst_286_20.
- Outcomes of Patients with Splenic Marginal Zone Lymphoma Treated with Rituximab or Splenectomy: Report from Tertiary Cancer Center in India- DOI: https://doi.org/10.1016/j.clml.2018.07.216.
- Patil VM, Noronha V, Joshi A, Mandal TK, Bhattacharjee A, Goel A, et al. Hypothyroidism post-chemoradiation on outcomes in head-and-neck cancer. Cancer Res Stat Treat 2018; 1:84-91. https://www.crstonline.com/text.asp?2018/1/2/84/258535.
- Choudhary, A.K., Abraham, G., Patil, V.M. et al. Audit of Demographics, Treatment Patterns and Outcomes of Differentiated Thyroid Cancers Treated with Tyrosine Kinase Inhibitors. Indian J Surg Oncol (2021). https://doi.org/10.1007/s13193-021-01445-y.
- Mandal TK, Roy S, Singh S, Lali BS, Chowdhury Z, Nayak L. Blastic plasmacytoid dendritic cell neoplasm of the thigh: A case report and narrative review of the literature. Cancer Res Stat Treat [serial online] 2020 [cited 2021 Dec 8]; 3:630-4. Available from: https://www.crstonline.com/text.asp?2020/3/3/630/295540.
- Srinivas S, Roy S, Mandal TK, Das S. A Varanasi experience. Cancer Res Stat Treat [serial online] 2020 [cited 2021 Dec 8];3:160-1. Available from: https://www.crstonline.com/text.asp?2020/3/1/160/279083.
- Kanteti, A.P.K., Abraham, G., Patil, V.M. et al. An Audit of Systemic Therapy in Medullary Carcinoma Thyroid. Indian J Surg Oncol (2021). https://doi.org/10.1007/s13193-021-01381-x.
- Roy S, Mandal TK, Nayak L, Gupta A, Shetty DL. Primary osseous Burkitt lymphoma mimicking multiple myeloma – A case report and literature review. J Appl Hematol [serial online] 2021 [cited 2021 Dec 8];12:37-40. Available from: https://www.jahjournal.org/text.asp?2021/12/1/37/311324.
- Venetoclax – The Game-changer in Hematology- CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2020; 41(04): 555-558. DOI: 10.4103/ijmpo.ijmpo_260_20.
- Cutaneous Involvement of Systemic Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma- CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2020; 41(02): 239-240. DOI: 10.4103/ijmpo.ijmpo_72_20.
- Splenic marginal zone lymphoma relapsing as miliary lung mottling: an unusual presentation- DOI: https://doi.org/10.5045/br.2018.53.2.103.
- Subarachnoid haemorrhage caused by Moya Moya disease with no intracranial aneurysm-A rare case report. Indian Medical Journal, Volume-108, 15 December 2014 Annexure. pISSN No.-0091-5871.
- A case of Disseminated NCC infection as Immune Reconstitution Inflammatory Syndrome in an HIV patient""- Indian Medical Journal, Volume-108, 15 September 2014 Annexure. pISSN No.-0091-5871.
Languages Spoken
Overview
Fellowship & Membership
Awards & Achievements
Talks & Publications
- World Eligibility for Treatment-Free Remission in Chronic Myeloid Leukaemia Patients from a Tertiary Cancer Centre in India – presented at the international CML conference-2017 (iCMLf).
- Long-term and short-term outcomes in patients of chronic myeloid leukaemia treated with generic and innovator imatinib- a retrospective analysis- presented at international CML conference-2017 (iCMLf).
- Outcomes of Chronic Myeloid Leukemia-Chronic Phase Patients Treated with Generic Imatinib- Report from Tata Memorial Hospital- oral presentation in Annual meeting for Mumbai Hematology Group - March 2018.
- Trastuzumab Emtansine in HER2 positive metastatic breast cancer: A real-world experience - e poster in ASCO- 2018, ASCO Abstract #226633.
- ESMO (European society of medical oncologists)
- ISMPO (Indian society of medical and paediatric oncologists)
- ASCO (American society of clinical oncologists)
- IOSI (Immune-oncological Society of India)
- Bengali
- English
- Hindi
- RMAC study: A randomised study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation, Oral Oncology, Volume 128,2022,105816, ISSN 1368-8375, https://doi.org/10.1016/j.oraloncology.2022.105816.
- Osteosarcoma journey over two decades in India: Small steps, big changes- Pediatric Blood Cancer. 2019;66:e27877. https://doi.org/10.1002/pbc.27877.
- Influence of hypothyroidism post chemoradiation on outcomes in head and neck cancer- DOI: 10.1200/JCO.2018.36.15_suppl.e18066 Journal of Clinical Oncology 36, no. 15_suppl. Published online June 01, 2018.
- Demography and pattern of care of patients with head-and-neck carcinoma: Experience from a tertiary care centre in North India- DOI: 10.4103/crst.crst_286_20.
- Outcomes of Patients with Splenic Marginal Zone Lymphoma Treated with Rituximab or Splenectomy: Report from Tertiary Cancer Center in India- DOI: https://doi.org/10.1016/j.clml.2018.07.216.
- Patil VM, Noronha V, Joshi A, Mandal TK, Bhattacharjee A, Goel A, et al. Hypothyroidism post-chemoradiation on outcomes in head-and-neck cancer. Cancer Res Stat Treat 2018; 1:84-91. https://www.crstonline.com/text.asp?2018/1/2/84/258535.
- Choudhary, A.K., Abraham, G., Patil, V.M. et al. Audit of Demographics, Treatment Patterns and Outcomes of Differentiated Thyroid Cancers Treated with Tyrosine Kinase Inhibitors. Indian J Surg Oncol (2021). https://doi.org/10.1007/s13193-021-01445-y.
- Mandal TK, Roy S, Singh S, Lali BS, Chowdhury Z, Nayak L. Blastic plasmacytoid dendritic cell neoplasm of the thigh: A case report and narrative review of the literature. Cancer Res Stat Treat [serial online] 2020 [cited 2021 Dec 8]; 3:630-4. Available from: https://www.crstonline.com/text.asp?2020/3/3/630/295540.
- Srinivas S, Roy S, Mandal TK, Das S. A Varanasi experience. Cancer Res Stat Treat [serial online] 2020 [cited 2021 Dec 8];3:160-1. Available from: https://www.crstonline.com/text.asp?2020/3/1/160/279083.
- Kanteti, A.P.K., Abraham, G., Patil, V.M. et al. An Audit of Systemic Therapy in Medullary Carcinoma Thyroid. Indian J Surg Oncol (2021). https://doi.org/10.1007/s13193-021-01381-x.
- Roy S, Mandal TK, Nayak L, Gupta A, Shetty DL. Primary osseous Burkitt lymphoma mimicking multiple myeloma – A case report and literature review. J Appl Hematol [serial online] 2021 [cited 2021 Dec 8];12:37-40. Available from: https://www.jahjournal.org/text.asp?2021/12/1/37/311324.
- Venetoclax – The Game-changer in Hematology- CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2020; 41(04): 555-558. DOI: 10.4103/ijmpo.ijmpo_260_20.
- Cutaneous Involvement of Systemic Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma- CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2020; 41(02): 239-240. DOI: 10.4103/ijmpo.ijmpo_72_20.
- Splenic marginal zone lymphoma relapsing as miliary lung mottling: an unusual presentation- DOI: https://doi.org/10.5045/br.2018.53.2.103.
- Subarachnoid haemorrhage caused by Moya Moya disease with no intracranial aneurysm-A rare case report. Indian Medical Journal, Volume-108, 15 December 2014 Annexure. pISSN No.-0091-5871.
- A case of Disseminated NCC infection as Immune Reconstitution Inflammatory Syndrome in an HIV patient""- Indian Medical Journal, Volume-108, 15 September 2014 Annexure. pISSN No.-0091-5871.
Dr. Mandal completed his MBBS from N.R.S Medical College, Kolkata in the year of 2008. Following this he completed his M.D. in General Medicine from Calcutta National Medical College, Kolkata in 2015, his D.M. in Medical Oncology from Tata Memorial Hospital, Mumbai 2019. Further, he holds an MRCP in the field of Medical Oncology (Specialty Certificate Examination) and accomplished it in the year 2019, and in the same year, he derived his ESMO certification, thus known as a certified practising consultant medical oncologist henceforth. Dr Mandal specialises in the treatment of oncological and haematological disorders such as managing solid tumours like gastrointestinal, genitourinary, lung, head and neck, gynaecological, breast cancers and haematological malignancies like acute leukaemias, multiple myeloma and lymphomas. He has also been part of many clinical trials.
Awards & Achievements
Fellowship & Membership
Languages Spoken
Talks & Publications
Overview
- RMAC study: A randomised study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation, Oral Oncology, Volume 128,2022,105816, ISSN 1368-8375, https://doi.org/10.1016/j.oraloncology.2022.105816.
- Osteosarcoma journey over two decades in India: Small steps, big changes- Pediatric Blood Cancer. 2019;66:e27877. https://doi.org/10.1002/pbc.27877.
- Influence of hypothyroidism post chemoradiation on outcomes in head and neck cancer- DOI: 10.1200/JCO.2018.36.15_suppl.e18066 Journal of Clinical Oncology 36, no. 15_suppl. Published online June 01, 2018.
- Demography and pattern of care of patients with head-and-neck carcinoma: Experience from a tertiary care centre in North India- DOI: 10.4103/crst.crst_286_20.
- Outcomes of Patients with Splenic Marginal Zone Lymphoma Treated with Rituximab or Splenectomy: Report from Tertiary Cancer Center in India- DOI: https://doi.org/10.1016/j.clml.2018.07.216.
- Patil VM, Noronha V, Joshi A, Mandal TK, Bhattacharjee A, Goel A, et al. Hypothyroidism post-chemoradiation on outcomes in head-and-neck cancer. Cancer Res Stat Treat 2018; 1:84-91. https://www.crstonline.com/text.asp?2018/1/2/84/258535.
- Choudhary, A.K., Abraham, G., Patil, V.M. et al. Audit of Demographics, Treatment Patterns and Outcomes of Differentiated Thyroid Cancers Treated with Tyrosine Kinase Inhibitors. Indian J Surg Oncol (2021). https://doi.org/10.1007/s13193-021-01445-y.
- Mandal TK, Roy S, Singh S, Lali BS, Chowdhury Z, Nayak L. Blastic plasmacytoid dendritic cell neoplasm of the thigh: A case report and narrative review of the literature. Cancer Res Stat Treat [serial online] 2020 [cited 2021 Dec 8]; 3:630-4. Available from: https://www.crstonline.com/text.asp?2020/3/3/630/295540.
- Srinivas S, Roy S, Mandal TK, Das S. A Varanasi experience. Cancer Res Stat Treat [serial online] 2020 [cited 2021 Dec 8];3:160-1. Available from: https://www.crstonline.com/text.asp?2020/3/1/160/279083.
- Kanteti, A.P.K., Abraham, G., Patil, V.M. et al. An Audit of Systemic Therapy in Medullary Carcinoma Thyroid. Indian J Surg Oncol (2021). https://doi.org/10.1007/s13193-021-01381-x.
- Roy S, Mandal TK, Nayak L, Gupta A, Shetty DL. Primary osseous Burkitt lymphoma mimicking multiple myeloma – A case report and literature review. J Appl Hematol [serial online] 2021 [cited 2021 Dec 8];12:37-40. Available from: https://www.jahjournal.org/text.asp?2021/12/1/37/311324.
- Venetoclax – The Game-changer in Hematology- CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2020; 41(04): 555-558. DOI: 10.4103/ijmpo.ijmpo_260_20.
- Cutaneous Involvement of Systemic Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma- CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2020; 41(02): 239-240. DOI: 10.4103/ijmpo.ijmpo_72_20.
- Splenic marginal zone lymphoma relapsing as miliary lung mottling: an unusual presentation- DOI: https://doi.org/10.5045/br.2018.53.2.103.
- Subarachnoid haemorrhage caused by Moya Moya disease with no intracranial aneurysm-A rare case report. Indian Medical Journal, Volume-108, 15 December 2014 Annexure. pISSN No.-0091-5871.
- A case of Disseminated NCC infection as Immune Reconstitution Inflammatory Syndrome in an HIV patient""- Indian Medical Journal, Volume-108, 15 September 2014 Annexure. pISSN No.-0091-5871.
Dr. Mandal completed his MBBS from N.R.S Medical College, Kolkata in the year of 2008. Following this he completed his M.D. in General Medicine from Calcutta National Medical College, Kolkata in 2015, his D.M. in Medical Oncology from Tata Memorial Hospital, Mumbai 2019. Further, he holds an MRCP in the field of Medical Oncology (Specialty Certificate Examination) and accomplished it in the year 2019, and in the same year, he derived his ESMO certification, thus known as a certified practising consultant medical oncologist henceforth. Dr Mandal specialises in the treatment of oncological and haematological disorders such as managing solid tumours like gastrointestinal, genitourinary, lung, head and neck, gynaecological, breast cancers and haematological malignancies like acute leukaemias, multiple myeloma and lymphomas. He has also been part of many clinical trials.
- ESMO (European society of medical oncologists)
- ISMPO (Indian society of medical and paediatric oncologists)
- ASCO (American society of clinical oncologists)
- IOSI (Immune-oncological Society of India)
- Bengali
- English
- Hindi
- World Eligibility for Treatment-Free Remission in Chronic Myeloid Leukaemia Patients from a Tertiary Cancer Centre in India – presented at the international CML conference-2017 (iCMLf).
- Long-term and short-term outcomes in patients of chronic myeloid leukaemia treated with generic and innovator imatinib- a retrospective analysis- presented at international CML conference-2017 (iCMLf).
- Outcomes of Chronic Myeloid Leukemia-Chronic Phase Patients Treated with Generic Imatinib- Report from Tata Memorial Hospital- oral presentation in Annual meeting for Mumbai Hematology Group - March 2018.
- Trastuzumab Emtansine in HER2 positive metastatic breast cancer: A real-world experience - e poster in ASCO- 2018, ASCO Abstract #226633.
Talks & Publications
Overview
Fellowship & Membership
Languages Spoken
Awards & Achievements
Refund Policy
1) Up to 4 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation can be done with full refund of the payment.
2) Up to 2 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation of appointment and refund with a cancellation charge of Rs.100/-.
3) Less than 2 hrs of appointment time:
Rescheduling / cancellation of appointment cannot be done, payment non-refundable in this case. However, Units can have the discretion to refund / reschedule in case of exigencies.
Please note : While making the payment online, above mentioned payment terms and conditions should be agreed upon by customers, by clicking in a box ( I agree) and then proceed for payment.
PATIENT CONSENT FOR TELEMEDICINE / TELECONSULTATION
Telemedicine involves the use of electronic communications to enable Hospitals/health care centres to provide healthcare services at different locations through exchange of information and for the purpose of improving patient care. I, confirm that I have received the necessary information to sign this form and I agree to take part in a live telemedicine/teleconsultation session with Manipal Hospitals.
I understand that:
- Interactive audio/video connection, electronic information and communication technologies shall be used for providing me with a telemedicine/teleconsultation.
- In case the information obtained via teleconsultation is not sufficient to make a diagnosis, I may be required to go to Manipal Hospitals for in-person consultation.
- Though the telemedicine/teleconsultation is private, other individuals, medical and non-medical, may be present to facilitate the consultation and that they will take reasonable steps to maintain confidentiality of the information obtained.
- A limited visual examination will take place during the telemedicine/teleconsultation and that it cannot replace a full medical examination done physically at Manipal Hospitals.
- I have the right to withhold or withdraw my consent to the use of telemedicine/teleconsultation in the course of my care at any time, without affecting my right to future care or treatment. I may also revoke my consent orally or in writing at any time.
- I may be prescribed medicines for treatment or/and diagnostic tests to further evaluate my health condition. All prescription will be sent to my registered email/phone no. Manipal Hospitals will keep a record of the consultation & prescription in my medical record.
- The telemedicine/teleconsultation services are not in any way intended to be used in case of an emergency.
- There can be potential risks with this technology e.g information transmitted may not be sufficient to allow for appropriate medical decision, the video /audio may disconnect/stop in-between, security protocols could fail causing a breach of privacy of personal medical information.
- Any relevant medical information about me including details of my medical history, examinations, x-rays, tests, photographs or other images may be transmitted /shared by Manipal Hospitals with their staff, specialist, business partners for the purpose of record, communications, feedback, enquires, follow ups, analysis etc.
- Manipal Hospitals responsibility shall terminate upon conclusion of this teleconference.
- I hereby consent that in consideration for the telemedicine / teleconsultation services rendered to me, I agree to pay the relevant charges.
- I hereby release Manipal Hospitals, its personnel and any other person participating in my care from any and all liability which may arise from authorized use of such Video / E-Consultation, Videotapes, Digital recording films and Photographs. I have read this document and understand the risk of the telemedicine / teleconsultation.
- I hereby consent to participate in a telemedicine / teleconsultation under the terms & conditions described in this document.
